Fundamental research enhances understanding of major cancer gene

(Babraham Institute) A collaboration between Babraham Institute scientists and AstraZeneca provides new insights into the role of PTEN, a major cancer gene, in controlling cell growth and behaviour. PTEN is the second most commonly altered gene in human cancers, particularly prostate cancers, and this work could help to develop and target new treatments.